阿奇霉素联合头孢曲松钠治疗重症社区获得性肺炎

Combining azithromycin with ceftriaxone sodium for treating severity community acquired pneumonia

目的观察阿奇霉素联合头孢曲松钠治疗重症社区获得性肺炎的临床疗效。方法随机将112例患者分为3组,A组32例,阿奇霉素针500mg/d;B组41例,头孢曲松钠针2～3g/d;C组39例,阿奇霉素针500mg/d和头孢曲松钠针2～3g/d。观察临床有效率,并对结果进行统计学分析。结果C组有效率明显高于对照组A、B。结论阿奇霉素联合头孢曲松钠治疗重症社区获得性肺炎优于上述单种抗生素。

Objective To investigate the clinicial efficacy of combining azithromycin with ceftriaxone sodium for treating severity community acquired pneumonia. Methods One hundred and twelve cases were randomly divided into three groups of thirty two patients in group A with azithromycin 500mg/d, forty one in group B with ceftriaxone sodium 2-3g/d and thirty nine in group C with azithromycin 500mg/d and ceftriaxone sodium 2-3g/d simultaneously. The clinical effective rate was observed and analyzed statistically. Results There was a better efficacy in group C than the other groups （P〈0.05）. Conclusion There is a better efficacy of combining azithromycin with ceftriaxone sodium for treating severity community acquired pneumonia than azithromycin or ceftriaxone sodium used individually.